Disclosures for "Establishing Psychometric Evidence of the Novel Patient-reported Functional Impacts of Narcolepsy Instrument (FINI) Using Data from Observational and Phase 2 Clinical Trials in Narcolepsy"
-
Dr. romero has received personal compensation for serving as an employee of Takeda. Dr. romero has stock in Takeda.
-
Dr. Savva has stock in Takeda. Dr. Savva has stock in Thermo Fischer.
-
Dr. Doll has nothing to disclose.
-
Dr. Howerter has received personal compensation for serving as an employee of Clinical Outcomes Solutions.
-
Dr. Dave has nothing to disclose.
-
Dr. Crawford has received personal compensation for serving as an employee of Takeda. Dr. Crawford has stock in Takeda.